Skip to main content
JIN YANG PHARMACEUTICAL. CO., LTD logo

JIN YANG PHARMACEUTICAL. CO., LTD — Investor Relations & Filings

Ticker · 007370 ISIN · KR7007370000 KO Manufacturing
Open in API
Filings indexed 210 across all filing types
Latest filing 2019-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 007370

About JIN YANG PHARMACEUTICAL. CO., LTD

https://www.jinyangpharm.com/

JIN YANG PHARMACEUTICAL. CO., LTD. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products, with a primary focus on prescription drugs. The company operates a fully automated, high-tech manufacturing facility. Its research and development efforts are dedicated to creating advanced preventive and therapeutic treatments for various diseases. Key areas of R&D include the development of anticancer drugs through molecular biology research, particularly for leukemia, and therapies for metabolic disorders such as diabetes and obesity. The company also develops antivirals and explores formulations based on herbal preparations.

Recent filings

Filing Released Lang Actions
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Jinyang Pharmaceutical Co., Ltd. for the period ending March 31, 2019. It contains detailed financial data, business operations, production capacity, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Korean
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Jinyang Pharmaceutical Co., Ltd. for the fiscal year 2018 (41st period). It contains comprehensive financial data, management discussion, business operations, and corporate governance details, which is the standard format for an annual report in the South Korean regulatory system (DART). It is not an announcement or a summary, but the full report itself. FY 2018
2019-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (Annual General Meeting). It details the approval of financial statements, dividend declarations, election of directors, and amendments to business purposes. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-03-22 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director (사외이사). It details the name of the director, the reason for resignation, and the effective date. This falls under the category of board or management changes.
2019-03-22 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 95% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사). It details the name of the appointee, their term, and their professional background. This falls under the category of board management and changes in corporate governance structure, specifically categorized as Board/Management Information (MANG).
2019-03-22 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Jinyang Pharmaceutical. It provides a summary of the audit opinion (unqualified/proper) and key financial data (assets, liabilities, profit/loss) for the fiscal year. While it contains financial data, it is a standard regulatory disclosure announcement regarding the submission of the audit report to the exchange, rather than the full audit report document itself. Therefore, it fits the 'Report Publication Announcement' (RPA) category. FY 2018
2019-03-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.